VIRMA and hepatocellular carcinoma: These findings were consistent with previous studies, which reported the upregulation of KIAA1429 (Lan et al., 2019) and YTHDF1 (Zhao et al., 2018), and downregulation of METTL14 (Ma et al., 2017) and YTHDF2 (Hou et al., 2019) in HCC.